InflaRx N.V. ( IFRX) - Key Metrics
IFRX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $0 | -$0.13 | -$0.05 | -$0.05 |
| 2025Q3 | $0 | -$0.18 | -$0.13 | -$0.13 |
| 2025Q2 | $0 | -$0.21 | -$0.11 | -$0.11 |
| 2025Q1 | ? | -$0.13 | -$0.22 | -$0.22 |
IFRX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -1.64 |
| 2025Q3 | ? | -1.58 |
| 2025Q2 | ? | -0.79 |
| 2025Q1 | ? | -1.79 |
IFRX
Price: $1.74
52 week price:
Earnings Per Share: -0.74 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: Germany
Volume: 38219
Market Capitalization: 153.1 million